Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Metabolic Brain Disease
|
November 14, 2016
Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE
Gerald Kircheis
Journal of Gastroenterology and Hepatology
|
December 11, 2002
Management of hepatic encephalopathy
Gerald Kircheis, Dieter Häussinger
Drugs
|
February 2, 2019
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy
Gerald Kircheis, Stefan Lüth
Gut
|
July 13, 2013
Correct determination of critical flicker frequency is mandatory when comparisons to other tests are made
Gerald Kircheis, Norbert Hilger, Dieter Häussinger
Journal of Gastroenterology and Hepatology
|
December 11, 2002
Pathogenesis of hepatic encephalopathy
Dieter Häussinger, Freimut Schliess, Gerald Kircheis
Gastroenterology
|
December 25, 2013
Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy
Gerald Kircheis, Norbert Hilger, Dieter Häussinger
Gastroenterology
|
February 10, 2015
Reply: To PMID 24365582
Gerald Kircheis, Norbert Hilger, Dieter Häussinger
Hepatology (Baltimore, Md.)
|
February 5, 2002
Critical flicker frequency for quantification of low-grade hepatic encephalopathy
Gerald Kircheis, Matthias Wettstein, Lars Timmermann, et al.
Journal of Hepatology
|
September 18, 2007
Assessment of low-grade hepatic encephalopathy: a critical analysis
Gerald Kircheis, Wolfgang E Fleig, Roman Görtelmeyer, et al.
Digestive Diseases (Basel, Switzerland)
|
June 12, 2024
Assessment of Cirrhotic Patients by the EncephalApp Fails to Predict Low-Grade Hepatic Encephalopathy
Rebecca Maria Neye, Gerald Kircheis, Daria Stratmann, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Metabolic Brain Disease
|
November 14, 2016
Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE
Gerald Kircheis
Journal of Gastroenterology and Hepatology
|
December 11, 2002
Management of hepatic encephalopathy
Gerald Kircheis, Dieter Häussinger
Drugs
|
February 2, 2019
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy
Gerald Kircheis, Stefan Lüth
Gut
|
July 13, 2013
Correct determination of critical flicker frequency is mandatory when comparisons to other tests are made
Gerald Kircheis, Norbert Hilger, Dieter Häussinger
Journal of Gastroenterology and Hepatology
|
December 11, 2002
Pathogenesis of hepatic encephalopathy
Dieter Häussinger, Freimut Schliess, Gerald Kircheis
Gastroenterology
|
December 25, 2013
Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy
Gerald Kircheis, Norbert Hilger, Dieter Häussinger
Gastroenterology
|
February 10, 2015
Reply: To PMID 24365582
Gerald Kircheis, Norbert Hilger, Dieter Häussinger
Hepatology (Baltimore, Md.)
|
February 5, 2002
Critical flicker frequency for quantification of low-grade hepatic encephalopathy
Gerald Kircheis, Matthias Wettstein, Lars Timmermann, et al.
Journal of Hepatology
|
September 18, 2007
Assessment of low-grade hepatic encephalopathy: a critical analysis
Gerald Kircheis, Wolfgang E Fleig, Roman Görtelmeyer, et al.
Digestive Diseases (Basel, Switzerland)
|
June 12, 2024
Assessment of Cirrhotic Patients by the EncephalApp Fails to Predict Low-Grade Hepatic Encephalopathy
Rebecca Maria Neye, Gerald Kircheis, Daria Stratmann, et al.
Page
of 4